Response to pegylated interferon in a COVID-19 positive male with metastatic jejunal neuroendocrine tumor treated with everolimus
Research output: Contribution to journal › Journal article › Research › peer-review
Documents
- Fulltext
Final published version, 170 KB, PDF document
A 61-year-old male on everolimus had chronic SARS-CoV-2 infection. Addition of pegylated interferon cleared viral RNA and supports combination therapy with everolimus plus interferon for COVID-19.
| Original language | English |
|---|---|
| Article number | e04218 |
| Journal | Clinical Case Reports |
| Volume | 9 |
| Issue number | 6 |
| ISSN | 2050-0904 |
| DOIs | |
| Publication status | Published - 2021 |
Bibliographical note
Publisher Copyright:
© 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
- infectious diseases, oncology, pharmacology
Research areas
ID: 305536585